Medical Weight Loss for Kenosha, Wisconsin Residents

Kenosha, Wisconsin residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving Kenosha through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Serving Kenosha, Wisconsin by telehealth: your consultation, prescription, and follow-ups all happen by secure video, with compounded medication shipped to your door. Our only physical clinic is in Costa Mesa, California; everything else is virtual. Doctor review just $119 (medication separate).

Why Kenosha Residents Choose New Hope Weight Loss

At New Hope Weight Loss, every case in Kenosha is overseen by a named physician, Dr. Anjmun Sharma, MD. You are not handed off to a rotating panel of strangers or a faceless intake bot. Dr. Sharma reviews your history, signs off on your plan, and stays accountable for it. That single point of medical responsibility is rare in telehealth, and it is the reason so many people across Wisconsin trust us to guide a serious decision about their health.

Kenosha residents do not need a local clinic to start. Our physician-led program is delivered by secure video from Costa Mesa, California, with flat nationwide pricing and compounded medication mailed in cold-pack packaging to your Kenosha address.

If you are searching for a weight-loss physician in Kenosha, the honest answer is that ours is in Costa Mesa, and thanks to telehealth that puts Wisconsin patients exactly where local ones are. We care for patients throughout Downtown, the lakefront, and the greater southeastern Wisconsin area. Our team supports you in English and Spanish, so you can ask questions in the language you are most comfortable with no matter where in Kenosha you are.

Getting started in Wisconsin takes a short physician visit by video this week, not a referral, a waitlist, or a trip to an office. The 90-day semaglutide program is $499, which works out to a lower monthly cost than paying month to month for many Kenosha patients. Wherever you live in Wisconsin, New Hope Weight Loss provides physician-supervised GLP-1 care by secure telehealth from our Costa Mesa, California clinic, with no need to travel for a visit.

GLP-1 Weight Loss Programs Available

Start with the 90-Day Metabolic Reset

Semaglutide anchors our most-requested program, and it shares an active ingredient with Wegovy and Ozempic. You can begin from $166 a month, or cover all 90 days for $499. In trials of the branded medication, average body-weight loss landed around 15 to 17 percent, though results vary and compounded semaglutide is neither FDA-approved nor brand-identical. Patients across Kenosha meet with Dr. Sharma entirely by telehealth.

Step up to tirzepatide when it fits

Priced from $233 a month, tirzepatide pairs GLP-1 with GIP for a dual effect. Branded-drug trials recorded up to 22.5 percent loss at qualifying doses, a ceiling figure, not an average. Same active ingredient as Mounjaro and Zepbound.

Everything opens with a $119 physician review. Medication billed separately. We take HSA, FSA, Klarna, and Affirm.

How Telehealth Works for Kenosha

The path from curious to treated is short, and it all runs through your screen. People in Kenosha start by completing a health-and-weight intake quiz online. Dr. Anjmun Sharma reviews every answer and meets you over secure video, usually within 48 hours, to talk through whether a compounded GLP-1 like semaglutide or tirzepatide fits your goals and history. When she prescribes, a state-licensed 503(a) pharmacy ships the medication to your Kenosha home in cold-pack packaging designed to keep it stable. After that, you and Dr. Sharma stay connected through video follow-ups, so your progress is supported from any corner of .

Frequently Asked Questions, Kenosha

Where is the New Hope Weight Loss location serving Kenosha?

The location serving Kenosha is our Costa Mesa, California clinic, which is our only physical site. We care for Kenosha, Wisconsin patients through telehealth rather than a local office. Dr. Anjmun Sharma confirms your eligibility for a compounded GLP-1 plan during a private video consult.

Is remote care a real option for Kenosha patients?

It is the standard for Kenosha. The whole program runs on telehealth, so consults, follow-ups, and support happen wherever you are. When Dr. Sharma approves you, compounded medication ships to Kenosha in cold-pack packaging engineered to keep it at a safe temperature in transit.

How much does a Kenosha patient pay overall?

The physician review is $119. Compounded semaglutide is offered from $166 monthly, or $499 for 90 days, and tirzepatide from $233 monthly. The medication is billed separately from the visit. We accept HSA, FSA, Klarna, and Affirm, and we apply no distance surcharge for Kenosha patients.

What areas of Kenosha do you serve?

We serve patients from across Kenosha by telehealth, including Downtown, the lakefront, and the greater southeastern Wisconsin area.

Are there hidden fees for Kenosha patients?

No. Kenosha patients pay the same flat, stated pricing: a $119 physician visit, then compounded semaglutide from $166/month or tirzepatide from $233/month with medication billed separately. There is no membership lock-in and no distance surcharge.

Kenosha Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving Kenosha, Wisconsin by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.